Hester acquires technology from ICAR – NIHSAD to develop Low Pathogenic Avian Influenza (H9N2…
The disease generally has low mortality rate up to six per cent, but can increase significantly in the presence of other…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Hester
Hester signs deal ICAR – IVRI for technology to develop Brucella Abortus S19 Delta per Vaccine
Hopes to launch the vaccine in 18 months